Pharmacokinetics Services Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066708
  • May 2021
  • Pharmaceuticals
  • 118 Pages
The Pharmacokinetics Services market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Pharmacokinetics Services market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Biologics Consulting Group, Inc., Certara, L.P., Eurofins Scientific, Inc., Evotec AG, GVK Biosciences Private Limited(Gvk Power & Infrastructure), Pacific BioLabs, Parexel International Corporation, Product Development, LLC(Jaguar Holding Company I, LLC), SGS SA, Shanghai Medicilon Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Pharmacokinetics Services market along with their effects over the forecast period. Similarly, according to the region Pharmacokinetics Services market research report includes the study of opportunities available in the market situation.

The Pharmacokinetics Services market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Pharmacokinetics Services Market:
The Pharmacokinetics Services market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Biologics Consulting Group, Inc., Certara, L.P., Eurofins Scientific, Inc., Evotec AG, GVK Biosciences Private Limited(Gvk Power & Infrastructure), Pacific BioLabs, Parexel International Corporation, Product Development, LLC(Jaguar Holding Company I, LLC), SGS SA, Shanghai Medicilon Inc.

Pharmacokinetics Services Market Segmentation Analysis:
By Drug Type
Small Molecules Pharmacokinetics Services
Large Molecules
Biopharmaceuticals Pharmacokinetics Services

Global Pharmacokinetics Services Market Segmentation by Regions:
In regional analysis, Pharmacokinetics Services market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Pharmacokinetics Services market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Pharmacokinetics Services Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Pharmacokinetics Services Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Pharmacokinetics Services Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Pharmacokinetics Services Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Pharmacokinetics Services Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Pharmacokinetics Services market, according to the key region.
  • To study the Pharmacokinetics Services market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Pharmacokinetics Services market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Pharmacokinetics Services research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Pharmacokinetics Services market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Pharmacokinetics Services market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Pharmacokinetics Services market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Pharmacokinetics Services market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Pharmacokinetics Services market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Biologics Consulting Group, Inc.
  • Certara, L.P.
  • Eurofins Scientific, Inc.
  • Evotec AG
  • GVK Biosciences Private Limited(Gvk Power & Infrastructure)
  • Pacific BioLabs
  • Parexel International Corporation
  • Product Development, LLC(Jaguar Holding Company I, LLC)
  • SGS SA
  • Shanghai Medicilon Inc.
  • Small Molecules Pharmacokinetics Services
  • Large Molecules
  • Biopharmaceuticals
  • Small Molecules Pharmacokinetics Services
  • Large Molecules
  • Biopharmaceuticals Pharmacokinetics Services

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Pharmacokinetics Services Market Snapshot
          2.1.1. Global Pharmacokinetics Services Market By Drug Type,2019
               2.1.1.1.Small Molecules Pharmacokinetics Services
               2.1.1.2.Large Molecules
               2.1.1.3.Biopharmaceuticals
          2.1.2. Global Pharmacokinetics Services Market By Drug Type,2019
               2.1.2.1.Small Molecules Pharmacokinetics Services
               2.1.2.2.Large Molecules
               2.1.2.3.Biopharmaceuticals Pharmacokinetics Services
          2.1.3. Global Pharmacokinetics Services Market By End-use,2019
          2.1.4. Global Pharmacokinetics Services Market By Geography,2019

3. Global Pharmacokinetics Services Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Type, 2020
     4.2. Global Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028

5. Global Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Drug Type, 2020
     5.2. Global Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028

6. Global Pharmacokinetics Services Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Pharmacokinetics Services Market Size (US$), By End-use, 2018 – 2028

7. Global Pharmacokinetics Services Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Pharmacokinetics Services Market Analysis, 2018 – 2028 
          7.2.1. North America Pharmacokinetics Services Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.2.3. North America Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.2.4. North America Pharmacokinetics Services Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Pharmacokinetics Services Market Analysis, 2018 – 2028 
          7.3.1.  Europe Pharmacokinetics Services Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.3.3. Europe Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.3.4. Europe Pharmacokinetics Services Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Pharmacokinetics Services Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Pharmacokinetics Services Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.4.3. Asia Pacific Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.4.4. Asia Pacific Pharmacokinetics Services Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Pharmacokinetics Services Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Pharmacokinetics Services Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.5.3. Latin America Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.5.4. Latin America Pharmacokinetics Services Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Pharmacokinetics Services Market Analysis, 2018 – 2028 
          7.6.1.  MEA Pharmacokinetics Services Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.6.3. MEA Pharmacokinetics Services Market Size (US$), By Drug Type, 2018 – 2028
          7.6.4. MEA Pharmacokinetics Services Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Pharmacokinetics Services Providers
        8.4.1 Biologics Consulting Group, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Biologics Consulting Group, Inc. Geographic Operations
                8.4.1.3 Biologics Consulting Group, Inc. Financial Information
                8.4.1.4 Biologics Consulting Group, Inc. Product Positions/Portfolio
                8.4.1.5 Biologics Consulting Group, Inc. Key Developments
        8.4.2 Certara, L.P.
                8.4.2.1 Business Description
                8.4.2.2 Certara, L.P. Geographic Operations
                8.4.2.3 Certara, L.P. Financial Information
                8.4.2.4 Certara, L.P. Product Positions/Portfolio
                8.4.2.5 Certara, L.P. Key Developments
        8.4.3 Eurofins Scientific, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Eurofins Scientific, Inc. Geographic Operations
                8.4.3.3 Eurofins Scientific, Inc. Financial Information
                8.4.3.4 Eurofins Scientific, Inc. Product Positions/Portfolio
                8.4.3.5 Eurofins Scientific, Inc. Key Developments
        8.4.4 Evotec AG
                8.4.4.1 Business Description
                8.4.4.2 Evotec AG Geographic Operations
                8.4.4.3 Evotec AG Financial Information
                8.4.4.4 Evotec AG Product Positions/Portfolio
                8.4.4.5 Evotec AG Key Developments
        8.4.5 GVK Biosciences Private Limited(Gvk Power & Infrastructure)
                8.4.5.1 Business Description
                8.4.5.2 GVK Biosciences Private Limited(Gvk Power & Infrastructure) Geographic Operations
                8.4.5.3 GVK Biosciences Private Limited(Gvk Power & Infrastructure) Financial Information
                8.4.5.4 GVK Biosciences Private Limited(Gvk Power & Infrastructure) Product Positions/Portfolio
                8.4.5.5 GVK Biosciences Private Limited(Gvk Power & Infrastructure) Key Developments
        8.4.6 Pacific BioLabs
                8.4.6.1 Business Description
                8.4.6.2 Pacific BioLabs Geographic Operations
                8.4.6.3 Pacific BioLabs Financial Information
                8.4.6.4 Pacific BioLabs Product Positions/Portfolio
                8.4.6.5 Pacific BioLabs Key Developments
        8.4.7 Parexel International Corporation
                8.4.7.1 Business Description
                8.4.7.2 Parexel International Corporation Geographic Operations
                8.4.7.3 Parexel International Corporation Financial Information
                8.4.7.4 Parexel International Corporation Product Positions/Portfolio
                8.4.7.5 Parexel International Corporation Key Developments
        8.4.8 Product Development, LLC(Jaguar Holding Company I, LLC)
                8.4.8.1 Business Description
                8.4.8.2 Product Development, LLC(Jaguar Holding Company I, LLC) Geographic Operations
                8.4.8.3 Product Development, LLC(Jaguar Holding Company I, LLC) Financial Information
                8.4.8.4 Product Development, LLC(Jaguar Holding Company I, LLC) Product Positions/Portfolio
                8.4.8.5 Product Development, LLC(Jaguar Holding Company I, LLC) Key Developments
        8.4.9 SGS SA
                8.4.9.1 Business Description
                8.4.9.2 SGS SA Geographic Operations
                8.4.9.3 SGS SA Financial Information
                8.4.9.4 SGS SA Product Positions/Portfolio
                8.4.9.5 SGS SA Key Developments
        8.4.10 Shanghai Medicilon Inc.
                8.4.10.1 Business Description
                8.4.10.2 Shanghai Medicilon Inc. Geographic Operations
                8.4.10.3 Shanghai Medicilon Inc. Financial Information
                8.4.10.4 Shanghai Medicilon Inc. Product Positions/Portfolio
                8.4.10.5 Shanghai Medicilon Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Pharmacokinetics Services Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Pharmacokinetics Services Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Pharmacokinetics Services Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Pharmacokinetics Services Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Pharmacokinetics Services Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Pharmacokinetics Services Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Pharmacokinetics Services Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Pharmacokinetics Services: Market Segmentation 
FIG. 2 Global Pharmacokinetics Services Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Pharmacokinetics Services Market, By Drug Type, 2019 (US$ Mn) 
FIG. 5 Global Pharmacokinetics Services Market, By Drug Type, 2019 (US$ Mn) 
FIG. 6 Global Pharmacokinetics Services Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Pharmacokinetics Services Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Pharmacokinetics Services Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Pharmacokinetics Services Providers, 2019
FIG. 11 Global Pharmacokinetics Services Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 12 Global Pharmacokinetics Services Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 13 Global Pharmacokinetics Services Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Pharmacokinetics Services Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Pharmacokinetics Services Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Pharmacokinetics Services Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Pharmacokinetics Services Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Pharmacokinetics Services Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Pharmacokinetics Services market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Pharmacokinetics Services Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Pharmacokinetics Services Market Value, By Segment1, 2018 – 2028
TABLE  North America Pharmacokinetics Services Market Value, By Segment2, 2018 – 2028
TABLE  North America Pharmacokinetics Services Market Value, By Country, 2018 – 2028
TABLE  Europe Pharmacokinetics Services Market Value, By Segment1, 2018 – 2028
TABLE  Europe Pharmacokinetics Services Market Value, By Segment2, 2018 – 2028
TABLE  Europe Pharmacokinetics Services Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Pharmacokinetics Services Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Pharmacokinetics Services Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Pharmacokinetics Services Market Value, By Country, 2018 – 2028
TABLE  Latin America Pharmacokinetics Services Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Pharmacokinetics Services Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Pharmacokinetics Services Market Value, By Country, 2018 – 2028
TABLE  MEA Pharmacokinetics Services Market Value, By Segment1, 2018 – 2028
TABLE  MEA Pharmacokinetics Services Market Value, By Segment2, 2018 – 2028
TABLE  MEA Pharmacokinetics Services Market Value, By Country, 2018 – 2028
TABLE  Biologics Consulting Group, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Certara, L.P.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eurofins Scientific, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Evotec AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GVK Biosciences Private Limited(Gvk Power & Infrastructure): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pacific BioLabs: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Parexel International Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Product Development, LLC(Jaguar Holding Company I, LLC): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SGS SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shanghai Medicilon Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Pharmacokinetics Services Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Pharmacokinetics Services Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Pharmacokinetics Services Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Pharmacokinetics Services Market, By Geography, 2019 (US$ Mn)
FIG.  Global Pharmacokinetics Services Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Pharmacokinetics Services Providers, 2016
FIG.  Global Pharmacokinetics Services Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Large Molecules Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biopharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pharmacokinetics Services Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Large Molecules Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biopharmaceuticals Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Pharmacokinetics Services Market Value, 2018 – 2028, (US$ Mn)